Nkrumah F K, Osei-Kwasi M, Dunyo S K, Koram K A, Afari E A
Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana, Legon, Ghana.
Bull World Health Organ. 1998;76(4):353-9.
In a randomized controlled trial in a measles endemic area, standard-dose (4.0 log10pfu) AIK-C measles vaccine administered at 6 months of age was compared to standard-dose Schwarz vaccine (3.7log10pfu) given at 9 months. Seroconversion rates at 3 and 6 months after immunization in the two groups were comparable and similar. The geometric mean titres achieved were, however, significantly higher in the Schwarz group (P < 0.05). No immediate serious side-effects were observed with either vaccine. We conclude that standard-dose AIK-C measles vaccine can be recommended for measles immunization in children below 9 months of age, especially in highly endemic and high-risk areas in developing countries.
在一个麻疹流行地区进行的随机对照试验中,将6月龄时接种的标准剂量(4.0 log10pfu)AIK-C麻疹疫苗与9月龄时接种的标准剂量施瓦茨疫苗(3.7log10pfu)进行了比较。两组免疫后3个月和6个月时的血清转化率相当且相似。然而,施瓦茨组达到的几何平均滴度显著更高(P<0.05)。两种疫苗均未观察到即刻严重副作用。我们得出结论,标准剂量的AIK-C麻疹疫苗可推荐用于9月龄以下儿童的麻疹免疫,特别是在发展中国家的高度流行和高风险地区。